Merit Medical Systems, Inc. (MMSI)
Market Cap | 5.72B |
Revenue (ttm) | 1.33B |
Net Income (ttm) | 120.04M |
Shares Out | 58.28M |
EPS (ttm) | 2.05 |
PE Ratio | 47.91 |
Forward PE | 27.56 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,065,980 |
Open | 95.94 |
Previous Close | 96.27 |
Day's Range | 95.68 - 99.04 |
52-Week Range | 70.70 - 108.08 |
Beta | 0.84 |
Analysts | Strong Buy |
Price Target | 105.60 (+7.51%) |
Earnings Date | Oct 30, 2024 |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bo... [Read more]
Financial Performance
In 2023, Merit Medical Systems's revenue was $1.26 billion, an increase of 9.24% compared to the previous year's $1.15 billion. Earnings were $94.41 million, an increase of 26.70%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for MMSI stock is "Strong Buy." The 12-month stock price forecast is $105.6, which is an increase of 7.51% from the latest price.
News
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that the WRAPSODY...
Merit Medical Announces Resignation of President, Joseph Wright
SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation o...
Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Fundus Camera Market Global Forecast Report by Product Type, End-User, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMark...
Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm c...
Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook...
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd...
Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...
Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
SOUTH JORDAN, Utah, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced it has signed a definitive asset purchase a...
Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months
Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians ...
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd...
Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
Second Quarter 2024 Highlights† Reported revenue of $338.0 million, up 5.6% Constant currency revenue* up 6.6% Constant currency revenue, organic,* up 5.0% GAAP operating margin of 13.6%, compared to ...
Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
SOUTH JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced plans to release findings from its WAVE stud...
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement ...
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...
Merit Medical: Undervalued With Multiple Growth Drivers In Play
Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY en...
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.
Merit Medical Launches basixSKY™ Inflation Device
Versatile analog device offers fast inflation and ease of use, streamlining patient care Versatile analog device offers fast inflation and ease of use, streamlining patient care
Merit Medical Shareholders Elect Silvia M. Perez as New Director
Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of Directors Experienced healthcare veteran brin...
Merit Medical Executive Leadership Team Update
Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems,...
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) ...
Merit Medical Systems, Inc. (MMSI) Q1 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Conference Call April 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and CEO Brian Lloyd - CLO and Corporat...
Merit Medical Reports Results for First Quarter Ended March 31, 2024
* Constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow are non-G...
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve succe...
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...